Bausch Health Companies Inc. [NYSE: BHC] stock went on a downward path that fall over -1.45% on Tuesday, amounting to a one-week price increase of more than 2.72%. The company report on October 13, 2022 that Bausch Health to Announce Third Quarter 2022 Results on Nov. 3.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Bausch Health Companies Inc. (NYSE
Over the last 12 months, BHC stock dropped by -75.81%. The average equity rating for BHC stock is currently 2.20, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $2.46 billion, with 362.20 million shares outstanding and 344.94 million shares in the current float. Compared to the average trading volume of 8.80M shares, BHC stock reached a trading volume of 3840803 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Bausch Health Companies Inc. [BHC]:
Truist have made an estimate for Bausch Health Companies Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 29, 2022. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $12 to $5. The new note on the price target was released on July 29, 2022, representing the official price target for Bausch Health Companies Inc. stock.
The Average True Range (ATR) for Bausch Health Companies Inc. is set at 0.49, with the Price to Sales ratio for BHC stock in the period of the last 12 months amounting to 0.30. Price to Free Cash Flow for BHC in the course of the last twelve months was 6.01 with Quick ratio for the last quarter at 0.90.
BHC Stock Performance Analysis:
Bausch Health Companies Inc. [BHC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.72. With this latest performance, BHC shares dropped by -8.12% in over the last four-week period, additionally sinking by -69.33% over the last 6 months – not to mention a drop of -75.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHC stock in for the last two-week period is set at 48.35, with the RSI for the last a single of trading hit 47.34, and the three-weeks RSI is set at 48.52 for Bausch Health Companies Inc. [BHC]. The present Moving Average for the last 50 days of trading for this stock 6.57, while it was recorded at 6.67 for the last single week of trading, and 14.55 for the last 200 days.
Insight into Bausch Health Companies Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Bausch Health Companies Inc. [BHC] shares currently have an operating margin of +18.69 and a Gross Margin at +55.31. Bausch Health Companies Inc.’s Net Margin is presently recorded at -11.24.
Return on Equity for this stock declined to -441.96, with Return on Assets sitting at -3.14.
Bausch Health Companies Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.90 and a Current Ratio set at 1.10.
BHC Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bausch Health Companies Inc. go to 8.70%.
Bausch Health Companies Inc. [BHC] Insider Position Details
There are presently around $1,664 million, or 66.80% of BHC stock, in the hands of institutional investors. The top three institutional holders of BHC stocks are: ICAHN CARL C with ownership of 34,721,118, which is approximately 0% of the company’s market cap and around 2.30% of the total institutional ownership; PAULSON & CO. INC., holding 26,439,035 shares of the stock with an approximate value of $179.52 million in BHC stocks shares; and VALUEACT HOLDINGS, L.P., currently with $97.38 million in BHC stock with ownership of nearly -0.621% of the company’s market capitalization.
155 institutional holders increased their position in Bausch Health Companies Inc. [NYSE:BHC] by around 43,744,781 shares. Additionally, 194 investors decreased positions by around 56,784,283 shares, while 68 investors held positions by with 144,553,159 shares. The mentioned changes placed institutional holdings at 245,082,223 shares, according to the latest SEC report filing. BHC stock had 46 new institutional investments in for a total of 5,674,510 shares, while 92 institutional investors sold positions of 31,960,960 shares during the same period.